
Core Viewpoint - Aier Eye Hospital announced the acquisition of partial equity in three medical institutions for a total amount of 105 million yuan, which is expected to enhance its market presence and operational efficiency [1] Group 1: Acquisition Details - The acquisition involves three medical institutions: Tongren Aier and Taojiang Aier, with a total transaction amount of 105 million yuan [1] - The payment for the acquisition will be made using the company's own funds [1] Group 2: Financial Performance - The three target medical institutions have shown a net profit growth from 11.5835 million yuan in 2023 to 13.8785 million yuan in 2024, representing a growth rate of 19.81% [1] - The institutions are currently in a period of improving efficiency and are expected to maintain continuous growth in performance [1] Group 3: Strategic Rationale - The target institutions have established a solid medical team and a good reputation in the local market, contributing to their increasing market share [1] - The timing of the acquisition is seen as advantageous for controlling costs and supporting the company's future development [1]